Sleep Disorder Market revenue to cross USD 20.5 Bn by 2027: Global Market Insights Inc.
January 12, 2022 06:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The sleep disorder market size is anticipated to record a valuation of USD 20.5 billion by 2027, according to the most recent study by...
ProSomnus® Sleep Technologies Adds John Remmers, MD, to Leadership Team
September 27, 2021 11:00 ET
|
ProSomnus Sleep Technologies
SAN FRANCISCO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies, the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced...
ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment
August 16, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the...
InvestorBrandNetwork Announces Relentless Dentist Podcast Featuring Vivos Therapeutics Inc. CEO R. Kirk Huntsman
June 09, 2021 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, June 09, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
Vivos Therapeutics to Participate at the Q1 Virtual Investor Summit
March 11, 2021 07:55 ET
|
Vivos Therapeutics Inc.
Vivos management to present at 1:30 pm Eastern Time on March 23, 2021 HIGHLANDS RANCH, Colo., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Vivos Therapeutics, Inc. (“the Company”)...
Vivos Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering
October 09, 2020 16:55 ET
|
Vivos Therapeutics Inc.
HIGHLANDS RANCH, Colorado, Oct. 09, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel and proprietary alternatives for...
RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer
August 03, 2020 15:11 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC: RSPI) (“RespireRx” or the “Company”), is pleased to announce that today, Mr. Tim Jones and RespireRx have...
Philips data-driven Mask Selector delivers unique patient and business benefits
July 09, 2020 09:30 ET
|
Royal Philips
July 9, 2020 First and only clinically-validated mask selection, sizing and fitting solution that helps providers fit patients with the right mask from the start [3]3D facial scanning...
InvestorBrandNetwork (IBN) Coverage Initiated for Vivos Therapeutics Inc.
June 11, 2020 08:30 ET
|
Vivos Therapeutics Inc.
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Vivos Therapeutics Inc., a company focused on addressing the root causes of mild to moderate sleep apnea, today announces it has...
REMSleep Holdings Eliminates Convertible Toxic Debt from its Balance Sheet
April 06, 2020 06:00 ET
|
REMSleep Holdings, Inc.
TAMPA, FL, April 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – REMSleep Holdings, Inc. (OTC PINK: RMSL) is happy to announce that it has eliminated convertible, toxic notes from its balance sheet....